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The objective of this empirical study was to understand the perspectives and
attitudes of policy-makers towards the use and impact of research in the health
sector in low- and middle-income countries. The study used data from
83 semi-structured, in-depth interviews conducted with purposively selected
policy-makers at the national level in Argentina, Egypt, Iran, Malawi, Oman and
Singapore. The interviews were structured around an interview guide developed
based on existing literature and in consultation with all six country investiga-
tors. Transcripts were processed using a thematic-analysis approach.
Policy-makers interviewed for this study were unequivocal in their support for
health research and the high value they attribute to it. However, they stated that
there were structural and informal barriers to research contributing to policy
processes, to the contribution research makes to knowledge generally, and to the
use of research in health decision-making specifically. Major findings regarding
barriers to evidence-based policy-making included poor communication and
dissemination, lack of technical capacity in policy processes, as well as the
influence of the political context. Policy-makers had a variable understanding of
economic analysis, equity and burden of disease measures, and were vague in
terms of their use in national decisions. Policy-maker recommendations
regarding strategies for facilitating the uptake of research into policy included
improving the technical capacity of policy-makers, better packaging of research
results, use of social networks, and establishment of fora and clearinghouse
functions to help assist in evidence-based policy-making.
Keywords Research to policy, evidence-based policy, health policy, Argentina, Egypt, Iran,
Malawi, Oman, Singapore
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KEY MESSAGES
 Key barriers to evidence-based policy-making cited by policy-makers included poor communication and dissemination of
research; lack of technical capacity in policy processes and their own inability to understand technical data; and the
diverse influences of the political context.
 Policy-makers had a variable understanding of economic analysis, notion of equity and burden of disease measures, and
were vague in terms of their use in national decisions.
 Policy-maker recommendations regarding strategies for facilitating the uptake of research into policy included improving
the technical capacity of policy-makers, better packaging of research results, use of social networks and institutional-
ization of an evidence clearinghouse function in ministries of health.
Introduction
The mismatch between the need for and investment in health
research was highlighted most notably by a report in 1990
which found that <10% of worldwide expenditure on health
research and development was devoted to problems that most
significantly affect more than 90% of the world’s population
(COHRED 1990). Approaches to addressing this ‘10/90’ gap
include research capacity strengthening, promotion of research
investments, and the establishment of global and national
health fora (COHRED 2000; WHO 2004). Empirical work on
mapping health resource flows, and health research systems
has also been initiated (Pang et al. 2003; Sadana and Pang
2003). There is a growing realization among researchers and
policy-makers of the necessity to carry out research to improve
management decisions and performance of national health
systems, as stated by the international development community
at the Mexico Summit on Health Research (Abbasi 2004).
Despite identification of the problem and willingness to solve it,
not enough is known about why policy-makers are not drawing
upon available information to make policy and planning
decisions.
The call for further exploration of research into policy processes
(Haines et al. 2004) has been strengthened by calls for engage-
ment of policy-makers in health research, and more surveys of
decision-makers (DeRoeck 2004); often these calls focus on the
developed world (Kindig et al. 2003; Hall 2004). Lavis et al. (2004)
point out that the clinical literature has more often examined
pathways from research to practice guidelines or to systematic
reviews. Global and national efforts have been made to consult
with policy-makers and research users (Lavis et al. 2005) and
invite them to be part of research processes, though empirical
work in this field is lacking, especially in low- and middle-income
countries (LMICs) (Hyder et al. 2007). There is a need to
understand how policy-makers view research and what will
stimulate them to promote and use health research. This will
ultimately enable researchers, translation experts, programme
managers and those in international organizations to facilitate
the process of research informing policy.
The overall goal of this pilot study was to understand the
perspectives and attitudes of policy-makers towards research,
and towards using research to inform health policy across a
spectrum of countries. The specific objectives were: (1) to pilot
test methodological approaches to empirical work on the
research-to-policy interface; (2) to understand the perceptions
and attitudes of policy-makers towards research evidence; and
(3) to define key barriers and facilitators for the integration of
research into policy across a number of national contexts. This
study aims to contribute to the methods and substantive
literature on integrating research and evidence into decisions in
the health sector, and does not claim to be representative of any
region or of the developing world.
Methods
For the purposes of this study, a policy-maker, or policy
decision-maker, was defined as an individual who has the
decision-making authority to sign policy documents, or allocate
funds at the national level. As a result, this study focused on
national (or federal) level decision-makers. Through semi-
structured, in-depth interviews with policy decision-makers in
Argentina, Egypt, Iran, Malawi, Oman and Singapore, investi-
gators documented previous experiences of policy-makers with
health research, explored the value placed on health research by
policy-makers, defined the context and conditions under which
policy-makers will demand health research, identified the
characteristics of health research that make it attractive to
policy-makers, and explored the attitudes of policy-makers
towards health researchers.
The interviews were structured around an interview guide
(sample in Annex 1) developed in consultation with all six
country investigators in a workshop held prior to the start of
data collection. Training of the six country investigators was
done by a leading qualitative methods researcher over the
course of three days and involved extensive country investigator
participation. Training activities included reviewing core meth-
odological issues involving informant selection, data manage-
ment and analysis, and determining the mix of qualitative
methods. Country investigators were asked to highlight local
cultural issues and to decide which interview guide topics were
most important. The interview guide also drew on existing
literature (Hanney et al. 2003), and had three components
exploring specific areas. It used a set of ‘core variables’ in the
form of questions that were used to collect standardized
information from all policy-makers (such as socio-demographic
information, affiliations, tenure). Next, the guide contained a
set of ‘key issues’ that were explored through open-ended
questions and used to examine attitudes and perspectives of
policy-makers (such as use of research, attitude towards
research and experience with researchers). Finally, the guide
contained probes to identify recent use of research in a policy
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decision and to ascertain familiarity with research and surveys
undertaken in their country.
Data were collected in each country by a team led by a senior
national scientist who had undergone training prior to the start
of the study. During the consent process, permission was
requested to tape-record the interview; if permission was
denied, the interviewer took detailed notes during the inter-
view. The tape-recording or interview notes were transcribed
and documented in verbatim transcripts in Microsoft Word
and checked by the local team. If the interview was carried out
in any other language than English, it was translated and
checked again. All transcripts were submitted to the study
coordinating centre at Johns Hopkins University (JHU) in
English. The only exception was Argentina, where the tran-
scripts were in Spanish since JHU had the capacity to analyse
data in both English and Spanish. All submitted transcripts
were stripped of identifiers or any identifying information.
Informed consent was sought from each informant and ethical
approval was obtained from Institutional Review Boards in
each country as well as at JHU.
The transcripts were reviewed for code words and a thematic
analysis was performed (Petticrew et al. 2004; Kapiriri and
Martin 2006; Green et al. 2007). Two members of the research
team first created codes by studying a sub-sample of
10 transcripts; these codes were then discussed and evolved
until a final set of codes had been generated. Once this set of
codes had been established, all transcripts were reviewed and
coded. Memo-writing assisted in defining these codes and the
linkages between them. Analysis focused on identification of
issues as well as examples of themes such as: experiences with
research, use of research, lack of research utilization, perceived
barriers to use of research and exploration of expressed value
and criteria by decision-makers. Since the intent was to identify
cross-cutting themes, the analytic approach did not focus on
differences between countries per se, or between types of
decision-makers.
The selection of countries was based on convenience and ease
of access, and on the suggestions of the Global Forum for
Health Research and the Eastern Mediterranean Regional Office
of the World Health Organization. Within countries, there was
an effort to recruit participants who were policy-makers in
different kinds of settings at the national level, such as
governmental ministries, health care organizations and research
institutions. A total of 83 interviews, comprising 22 women and
65 men, were conducted in the six countries (11–17 per
country) between November 2006 and November 2007.
Informants included Ministers of Health, Chairs of
Parliamentary Committees on Health, Director-Generals for
Health Affairs, Advisors to the Ministers of Health, and
Directors of health reform programmes, in addition to other
identified health policy-makers.
Results
Informants demonstrated considerable appreciation for re-
search, and its value in policy formulation. They enumerated
a series of constraints and facilitators for translation of research
results into policy, most notably inadequate or ineffective
communication of research results, limited capacity in-country
to conduct policy-relevant research and political constraints.
Communication and dissemination of evidence
Informants repeatedly stressed the importance of communica-
tion of research results to policy-makers such as:
‘‘The most important barrier is communication. Research is
produced but there are no formal channels for research findings
to be communicated to policy makers . . . I personally have my own
technical team, but beyond this small team, we neither have the
human skills or the resources to either conduct nor absorb research.
This is one of the most important barriers to using research results
to inform policy.’’
A perception that the interests and motivations of researchers
are at odds with those of policy-makers was expressed on many
occasions. This may point to the perceived differences in the
objectives of the two groups; as the policy-maker states:
‘‘I think there’s a gap [in] our objectives . . . researchers [are] trying
to find answers to an academic question, a policy-maker is trying to
solve a problem which sometimes is time-sensitive. So you may
need to move without the luxury, privilege, advantage of firm
information. And you need to make the judgment [between what]
you need to know and when you are willing to take a risk.’’
Suggestions for addressing communication barriers included
establishing a systemic approach to feeding research results to
policy-makers that did not rely on the personal preferences of
policy-makers, and promoting dialogue between policy-makers
and researchers. A starting-point was identified as better
packaging and language used in presenting research results.
Some policy-makers suggested that researchers should be
trained to bridge this communication gap between researchers
and policy-makers:
‘‘Yes, yes [the language] marketing, it is a process of educating the
researcher, to teach her/him to say in very few words or in
exceedingly little time what needs to be said, and this costs a lot of
effort, when you are talking about an investigator she/he needs her/
his time and gets angry if that time is not there, it is not a small
problem. There is a problem of production, of diffusion of
information, there is a problem of language as we said earlier,
there is a problem of how the time each of the partners are
investing is valued. I understand that for an investigator who has
spent a year doing a study, it seems horrible and sacrilegious to
summarize her/his research in two to three minutes.’’
Concomitantly, policy-makers also highlighted their own lack
of technical capacity as a key challenge:
‘‘Decision-makers also need technical training; if there is no
technical training and it is only a political function without
information related to the policies of the sector, it is probable that
you will make less use of information, there is less possibility of
grasping the [meaning of the] information and using it adequately,
and other times you don’t have enough technical advisors or the
corresponding team to [assist you to] make decisions. In other
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words it is either the lack of training or the lack of a team to help
you out if you yourself don’t have this training. And all this results
in the decisions taken being of lower quality, this is obvious.’’
They also mentioned that policy-makers needed technical
training on how to formulate policies on technical matters in
health.
Interestingly, while some informants stated that there is
overall limited research capacity, a greater number stated that
there is extensive capacity in basic science research, but limited
capacity in policy-related research. In one country, this was
attributed to the availability of funding from drug companies
for basic science research and promotion of drug/vaccine trials,
in contrast to the very limited funding available for research
with direct policy implications. In addition to the lack of
technical capacity, informants asserted that resource con-
straints, both in terms of manpower and of fiscal resources,
limited linking of research to policies:
‘‘The most important thing is [that] research findings are not used.
It is the lack of resources available to [hire] the researchers and to
disseminate the data. We tend to do what we have been doing the
previous years.’’
Underlying this perception was a consistent recognition of
‘organizational culture’ as a factor in determining the role of
research. This culture was thought to facilitate both the
generation and translation of research into policy. It appears
that the importance of a ‘research culture’ was considered by
some to be a prerequisite for evidence-based health
policy-making:
‘‘Basically we don’t possess a so called ‘research culture’ especially
in such a country where our . . . resources can be of much help in
purchasing instruments and latest technology. Absence of technol-
ogy is the reason for the failure of research because no one would be
motivated to do research in the absence of good incentives. I think
that it would take maybe 20, 30 or 40 years for a research culture
to pave its way.’’
Influence of the political context
The informants stated that depending on the type of policy and
government mandate, other political influences implicitly affect
policy. Legislative processes, parliamentary machinery and
budgetary policies were cited as important considerations in
research-to-policy processes, especially in the context of drug
procurement. The benefits of translating scientific research
results into policies were evaluated in the context of electoral
impact by some policy-makers:
‘‘Policy makers are sometimes more concerned about popularity and
being voted in, [than] to care to integrate scientific research results
into their policies; because maybe this may actually make them not
as popular as before with the voters.’’
Examination of the research-to-policy continuum requires
studying both how research results are translated into policy,
and assessment of legislation and institutional arrangements,
and the flexibility and opportunities they offer for the inclusion
of new research findings. As one policy-maker stated:
‘‘The role of research is very important in policy-making . . . how-
ever, the problem with [our] health sector is that it has not been
dynamic like [our economy] . . . Our legislation, structures and
way of doing things have not changed for years, and all the
information available now is dated. Without . . . research, we can
hardly work properly in this sector, and this is where we are trying
to build capacity within the Ministry for all concerned parties.’’
The link between politics and policies also affects the extent
to which policies can be (or are) based on research. Ultimately,
informants stated that it is national leadership in these
countries that retains a key role in taking responsibility for
the way the policy is formulated and the extent to which
research plays a role in policy-making. As declared in their
statements of values and vision:
‘‘The minister is the one who sets the vision. Then the political
agenda is discussed within the advisory committees of all
departments. In my department we have programmes and targets
which we set and [obtain] approval from the minister. Decisions in
our department are not taken by the minister alone, we set the
programme [but] he has to approve it.’’
Bridges between research and policy-making
Several recommendations were made by informants regarding
possible solutions for facilitating the uptake of research into
policy-making. In addition to improving the technical capacity
of policy-makers and packaging of research results, suggestions
also included the establishment of fora and clearinghouse
functions:
‘‘We want to establish what we call a clearinghouse mechanism.
We want to have an office composed of specialists who will be able
to look at those disseminated research results, critically analyse
them and advise Government and the appropriate ministry.’’
And:
‘‘There must be some forum where policy-makers can sit down and
discuss some studies or research results. Decisions are made
by . . . the policy-makers alone and I don’t think that is right.’’
This idea of a forum was a concept reiterated by many
policy-makers when asked what strategies they would recom-
mend to improve the dissemination and utilization of research
results. Even those who had worked in their respective
ministries of health in more of a technical capacity agreed that:
‘‘We need to have a good forum that assists to publish our data. We
have a lot of data just sitting . . . It is not a motive for us to
publish . . . There is no incentive . . . .’’
Systemic fissures between governmental departments and
implementing partners, as well as in the relationships between
researchers and policy-makers, were cited as being an import-
ant barrier against the linking of research findings to policies.
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Policy-makers from several countries proposed a more compre-
hensive and cohesive vision of linkages between policy-makers,
researchers and implementers:
‘‘The most important strategic solution to remove this gap [between
government and community/universities] is to use our own
resources. This gap has been rooted from culture and history, we
are living in a country having years of structural despotism and
have suffered enough and at this time its effect still can be felt . . .
And in order to make this change, we need inter-sectoral
cooperation. These changes must first take place in the government
sector, and ministers should make this structural organization a
priority with a scientific and futuristic outlook and make use of
international experiences.’’
Policy-makers also presented their conceptualization of work-
ing cohesively:
‘‘If we are to address these issues we need to work together,
policy-makers, researchers and implementers of various pro-
grammes. I am talking of the executive arm of Government. We
also need those research findings as a committee to guide our debate
in Parliament so that we are not seen to lag behind in information.
Otherwise . . . the quality of our debate in parliament has not lived
to the expectations of the public . . . in the health sector, I do not
think members of parliament can waste time quarrelling on useless
things when a lot of people are dying because of these issues.’’
Perspectives on economic analyses and equity
Policy-makers were asked about economic evaluations, such as
cost-effectiveness analysis, and burden of disease measures,
such as disability-adjusted life years (DALYs), and their use in
decisions. There was a wide spectrum of responses with some
policy-makers demonstrating apt knowledge of these concepts.
Others claimed familiarity, but when pressed for examples on
their understanding of cost-effectiveness analyses, they made
statements often mistaking the latter for cost-consciousness or
total cost savings. Seemingly contradictory statements by
policy-makers indicated these discrepancies:
‘‘I am not familiar with the DALY but cost-effectiveness is the most
important factor when making decisions. Cost-effectiveness is the
main priority in any decision taken. When we do the plan for the
population . . . for example, we need to make sure that if we spend
this amount on this decision/policy we will save spending more in
the long-run if we do not take this decision.’’
Others stated lack of use:
‘‘Yes of course [cost-effectiveness analysis] would be useful, but I
have to let you know that this is not used adequately [in this
country] as very few professionals know this kind of language.
However, this does not undermine its importance.’’
Policy-makers indicated the need to consult with the World
Health Organization amongst others to obtain information on
DALYs and questioned the usefulness of using this measure for
their countries.
‘‘Any way, this topic about DALY is an interesting story because
information on this matter has never been available in our
country . . . Does the indicator on DALY do good for our country?
DALY in some ways can give us an idea about cost effectiveness and
cost-benefit and also can give us an idea of the true variables . . .we
have to base our calculations, although our calculations are not
that correct.’’
Though more uncommon, policy-maker statements about
equity were generally favourable and staunchly in support of
equity-based policies. They recognized that there was a duty on
the part of government and civil society to ensure that the poor
are not left out of services, as they are usually the most
vulnerable in terms of their health. Many however, adamantly
indicated that equity was not a salient consideration because
there was no question about their mission of ensuring universal
health care accessibility. However, others were more frank
about the challenge of addressing equity:
‘‘Health equity has not been considered. We have talked so much
about equity but nothing much have been done about it. We have
no such mechanism in order to work on this part and to impose
equity in the country.’’
In spite of the promotion of considering equity, economic
analyses and burden of disease measures in national-level
health sector decision-making, they remain very much theor-
etical and abstract in the minds of our respondents.
Discussion
There is an extensive body of literature on the
research-to-policy process overall and most of it is from
high-income countries; and there is limited empirical work, or
application of standardized approaches, across multiple coun-
tries (Fielding et al. 2002; Petticrew et al. 2004; Watt et al. 2005;
Lavis 2006; St-Pierre et al. 2007). By exploring the opinions and
attitudes of policy-makers across six countries, this study is an
effort to further the global dialogue on both methods and
knowledge on the research–policy interface, with a special focus
on LMICs. This study was planned and implemented with the
intention of testing standardized methods and identifying
common themes critical to the research-to-policy process in
specific countries. The diversity in roles and responsibilities of
informants sampled, differences in country context, and the
very nature of semi-structured in-depth interviews, all provided
rich variation across informants and countries. The consistency
of themes arising across multiple informants in different
countries reflects considerable internal consistency in the
views of our informants; and provides a sample of opinions
and perspectives that demonstrate the value accorded to
research.
Acknowledging the differences between policy-makers and
researchers, identifying political issues and lack of resources are
common themes across policy-makers. Specific suggestions
were offered by policy-makers to help bridge the research-to-
policy gap. The importance of communication, the need for
policy-maker training, the role played by social linkages and the
call for a research culture are some that might be considered for
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action. The reality, which is often discussed within countries,
and is now understood empirically, was that knowing research-
ers socially and outside professional relations made
policy-makers more receptive to their research. The fact that
policy-makers might weigh research results against popularity
and vote gains was also discussed openly. Acknowledging these
influences is one of the first steps in moving ahead to explore
them further, especially to see if studies can elucidate the
implicit criteria used by policy-makers in such decisions.
Study informants suggested that policy-makers’ training can
critically affect their decision-making and the quality of
decisions taken. This provides another entry point for both
research and action: defining delivery strategies and content of
such training, as well as evaluating the impact of such training
are an important potential research agenda. Also implicit in
these statements was the recognition of a role for individuals
who are familiar with technical details but involved in policy
decisions—called ‘technocrats’ or ‘knowledge brokers’—within
otherwise bureaucratic structures (Sandiford et al. 1992). These
findings have important implications for developing joint
research agendas and strengthening research-to-policy
approaches in the health sector.
This study builds on and corroborates selected findings from
other work in developing countries (Table 1). Papers from
Mexico and Asia (Trostle et al. 1999; Healy et al. 2007)
categorized facilitators and barriers of exchanges between
researchers and policy-makers, including resource constraints,
the public’s role in decision-making, as well as differences in
language. Policy-makers in this study made similar recommen-
dations, including the establishment of fora to bring together
researchers and policy-makers. Albert et al. (2007) explored
factors influencing health research utilization by national
policy-makers involved in Mali’s national essential drugs list
and found that access to information, as well as relevance of
research, were perceived to play a role by informants, results
that parallel this study’s findings. Their conclusion that
improving the transfer of research to policy would require
effort on the part of researchers, policy-makers and third
parties was highlighted by policy-makers in this study as well,
with a specific focus on a clearinghouse mechanism to help
disseminate research, or an independent organization that
provides the link between policy-makers and researchers.
Aaserud et al. (2005) concluded that publication of important
trials is necessary but not sufficient to effect policy changes;
and that different intervention strategies are necessary depend-
ing on the context (Table 1). Another practical finding in this
study is that policy-makers believed that the way research was
presented is an important factor in the uptake of evidence into
policy-making. Lack of appropriate packaging of research
findings and dissemination within academic circles only were
also found to be barriers to research uptake by Hennink and
Stephenson (2005) and in the systematic review by Innvaer
et al. (2002). The latter also found that overall, the most
commonly reported facilitators were the inclusion of summaries
with policy recommendations, as well as personal contact
between researchers and policy-makers; the most commonly
reported barriers were absence of personal contact, lack of
timeliness or relevance of research, mutual mistrust, and power
and budget struggles. Though policy-makers indicated some T
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elements of mistrust towards researchers, these did not figure
prominently in this study.
Many of the previous studies focused on specific aspects of
research-to-policy processes, mainly involving a disease pro-
gramme, drug or drug list, whereas this study explored the
attitudes and perceptions of research-to-policy processes overall
in the health sector. Though there is no consensus on a
typology of policy categories suitable for assessing research
utilization (Lavis et al. 2002; Hyder et al. 2007), Hanney et al.
(2003) summarize models that have been shown to be most
relevant to analysing research utilization. They indicate that
different types of research are likely to be most relevant for
various levels and situations of policy-making. This study covers
national health policies and focuses on decisions at the central
(or federal) level; this is to be differentiated from policies made
at other levels. In fact, Black (2001) argues that research
evidence is more influential in central policy than local policy,
where policy-making is marked by negotiation and uncertainty.
The use of research depends on the degree of consensus on the
policy goal; it is used if it supports the consensus and is used
selectively if there is a lack of consensus. The policy-makers
interviewed in this study did not provide examples of the latter.
Rich and Oh (2000) posit three perspectives generally taken
in knowledge utilization studies: (1) the actions of a rational
decision-maker; (2) communication or linkage (e.g. the
two-communities theory metaphor); and (3) the product of
bureaucratic procedures. They recognize that a rationalistic bias
dominates the utilization literature. Though this study pur-
posefully did not prospectively adopt a theoretical perspective
for fear of inadvertently biasing the informants’ responses, we
agree that understanding theoretical mechanisms of research
utilization is an important aspect in the development and
evaluation of interventions aimed at fostering utilization and/or
impact, and that testing theories is an integral part of
advancing knowledge.
The results of this study lend support to Dobrow et al.’s
(2004) description of a practical–operational orientation (versus a
philosophical–normative orientation) of evidence, where ‘what
constitutes evidence is context-based . . . and evidence is defined
less by its quality, and more by its relevance, applicability or
generalizability to a specific context’. This study shows that this
may be a critical factor contributing to the lack of evidence-
based policy-making and the divide between researchers and
policy-makers; as the practical–operational orientation suggests
that timing and context strongly influence the definition of
evidence. Policy-makers in this study consistently recognized
the importance of the relevance of evidence, and expressed
openness to the types of evidence that are acceptable; these
include non-experimental evidence as well as research studies
published in scientific journals. As a result, research-based
evidence not only competes with other forms of evidence
during the process of affecting policy, but might be denied
space if not deemed to be immediately useful or timely.
Identifying perceived barriers to research use by policy-
makers lends itself to future research using a knowledge
transfer and exchange (KTE) framework (Healy 2007). As
described by Armstrong et al. (2006), KTE has been defined in
various ways but has generally focused on the application of
knowledge. Understanding the context in which users of
evidence sit provides valuable insight into effective methods
to support knowledge transfer. To move the KTE field further,
Mitton et al. (2007) argue that ‘the complexities of real-world
policy-making and the misalignment between the evidence
producers and the decision-makers suggest that other litera-
tures and disciplines, and indeed, other ways of thinking need
to be given greater weight in these discussions’. The
policy-makers in this study were also cognizant of the need
for incentivizing the engagement of researchers in problems
that are relevant and timely to their decisions.
This pilot study focused only on six countries and a selected
sample of national policy-makers within those countries; the
intent was to explore the use of an empirical approach to
understand these policy-makers. The opinions and ideas
expressed by policy-makers in this study provide a measure of
the range and depth of issues considered in the research-
to-policy interface. While a standardized approach was used
and a workshop provided training on data collection, it is
important to recognize the inherent variability in a semi-
structured approach; differences in interviewing styles between
investigators, and differing contexts may have affected the type
and depth of data collected. In addition, the translation of data
collected in other languages into English can be a source of loss
of information and culture-specific nuances (Bowden and
Fox-Rushby 2003). We acknowledge these types of limitation
and hope that the data and further work in this area will
address some of them.
Conclusion
It is important to note that policy-makers interviewed for this
study were unequivocal in their support of health research and
the high value they attribute to it, despite the stated structural
and informal barriers to research contributing to policy
processes. This value was expressed not only for the contribu-
tion research makes to knowledge generally, but also for the
use of research in decision-making processes specifically. From
the policy-maker’s perspective, six distinct potential measures
proposing a more comprehensive and cohesive vision of
linkages between policy-makers, researchers and implementers
are suggested (Box 1). These include strengthening demand
from policy-makers, creating formal processes to facilitate
dialogue between researchers and policy-makers, implementing
incentives for researchers, enhancing technical capabilities and
competencies, and improving the packaging of evidence.
Suggested actions that can be taken by policy-makers and
health researchers respectively are noted in Box 2. Both policy-
makers and health researchers could benefit from the existence
of a board or committee that includes policy-makers as well as
researchers to develop and/or approve government-funded or
donor-funded research that is relevant to policy and will be
used by policy-makers (Box 2). In helping to define how
systematic study of research-to-policy processes can promote
health research to policy-makers, these study results have
further potential applicability in defining how health research
programmes can better implement their activities and encour-
age the involvement of various stakeholders.
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Box 1 Suggested strategies to promote the integration of research into policies
Strengthening demand from policy-makers:
It is recognized that policy-making in LMICs depends on a host of other factors in addition to research, such as the political
structure and degree of socio-political and economic stability in the country. Political dynamics can often hold little place for
research to be incorporated into decisions. As a result policy-makers play a key role in demanding such evidence for use in
their decisions. Such demand has a strong influence on the supply or the generation of research evidence within their
countries.
Creating formal processes to facilitate dialogue:
Establishing a regular process where policy-makers can discuss studies or research results with scientists and researchers will
help build stronger relationships between the two communities. Joint workshops between policy-makers and country
researchers, a regular forum for interactions and interactive conferences are all options.
Improving packaging of evidence:
Researchers, communication units and knowledge brokers need to improve the synthesis, collation and presentation of
evidence for easy use by policy-makers. Enhancing the relevance of research results, using direct and clear language, and
highlighting the main lessons will allow policy-makers to focus their time and attention on significant research.
Enhancing technical capabilities and competencies:
Improving the technical capacity of policy-makers and policy-making processes to access, understand and utilize research
evidence will enhance policy-makers’ familiarity with technical concepts and promote use of evidence in decision-making.
Improving capacity can take several forms: a series of workshops, technical briefings, short courses or even mini-rotations of
policy-makers in research institutions. One longer term option is the establishment of a technical analysis unit within easy
access of the policy-maker with trained knowledge brokers.
Implementing incentives for researchers:
Incentivizing sustained involvement of researchers in health sector decision-making potentially addresses the lack of
technical capacity, as well as facilitates cooperation between researchers and policy-makers. Structural options might include
the establishment of health policy units with researchers. Financial options might include grants to researchers to be
available for quick access to policy-makers, or temporary secondments to support policy development. Non-financial
incentives to recognize the role of research in policy, encourage researchers to work with real life problems faced by the
national health system and recognize the contribution of evidence in decisions are important for sustainability.
Recognizing the role of informal relationships:
Policy-makers have acknowledged that they tend to pay careful attention to those researchers and scientists with whom they
have established personal relationships. On the one hand, this is important, since the trust that develops in such a
relationship allows for easy flow of information. On the other hand, to rely solely on individual relationships with each
researcher is clearly not feasible. As a result, the development of social networks between policy-makers and researchers may
be an important process not only to convey evidence but also to develop trust.
Box 2 Action items for researchers and policy decision-makers
Policy decision-makers could: Researchers could:
 Actively interact with health researchers; communi-
cate and suggest research areas for policy
implementation.
 Reach out to policy-makers and engage them early on
in the question-forming process.
 Promote research investments linked to specific
policies in development.
 Get involved in policy-making processes; communi-
cate with policy-makers better and more frequently;
demonstrate the utility of research results.
 Identify short-, mid- and long-term policy strategies
and identify points where evidence is missing and can
contribute.
 Ask policy-makers for questions that need to be
answered and problems that they are facing that need
to be solved.
 Have a board or committee that includes policy-makers as well as researchers to develop and/or approve
government-funded or donor-funded research that is relevant to policy and will be used by policy-makers.
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Annex 1
Examples of guiding questions for
semi-structured interviews
Characteristics and responsibilities of policy-makers
 Position and responsibilities?
 Education: physician, any formal training in public health,
administration/management, health economics or topics
relevant to policy-making?
The policy environment in the country
 Who sets the national health policy agenda and what are
the methods used?
 What sources of information do you use for policy-making?
 Have you yourself been presented with data on the costs of
different public health interventions, or their cost-effective-
ness? Do you think showing how much it costs to save one
life is useful to you as a policy-maker? Why (or why not?)
 What other factors could you consider when making
decisions?
Role of research
 In your opinion, what is the role of research and research
evidence in policy-making?
 How can health policies be better informed by research
evidence?
 What is the most recent policy decision you have made? Do
you recall using research evidence to make that decision?
 Do data on impact/effectiveness of interventions play a role
in your decision-making?
 What strategies would you recommend to improve the
dissemination and utilization of research evidence?
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